Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Terminated1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05352828Phase 1Active Not Recruiting
Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy
Classical Hodgkin LymphomaHodgkin Disease RecurrentHodgkin Disease Refractory
PrincipalinvestigatorStart date: 2022-07-25

Research Network

Collaboration Network

11 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05352828Phase 1PrincipalInvestigator

Autologous CD30.CAR-T in Combination With Nivolumab in cHL Patients After Failure of Frontline Therapy

Classical Hodgkin LymphomaHodgkin Disease RecurrentHodgkin Disease Refractory
Active Not Recruiting
NCT02169505Phase 2PrincipalInvestigator

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Lymphoma
Terminated

All 2 trials loaded